Insider · CIK 0002043411
Christiana Marie Cioffi
Files at FENC (FENNEC PHARMACEUTICALS INC.). First filing -, latest -.
In brief
Christiana Marie Cioffi files SEC Form 4 as officer at FENC (FENNEC PHARMACEUTICALS INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Christiana Marie Cioffi has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 16 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +3,946 | $5.53 | $22k | 28,746 | 18 h ago |
| Sep 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +156 | $0.00 | $0 | 24,800 | 14 d ago |
| Aug 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +156 | $0.00 | $0 | 24,644 | Aug 31, 2026 |
| Jul 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +156 | $0.00 | $0 | 24,488 | Aug 3, 2026 |
| Jun 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +156 | $0.00 | $0 | 24,332 | Jul 1, 2026 |
| May 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +156 | $0.00 | $0 | 24,176 | Jun 1, 2026 |
| Apr 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +155 | $0.00 | $0 | 24,020 | May 1, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +17,106 | $0.00 | $0 | 21,806 | Apr 2, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +158 | $0.00 | $0 | 21,964 | Apr 2, 2026 |
| Mar 28, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +1,901 | $0.00 | $0 | 23,865 | Apr 2, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +120,000 | $5.77 | $692k | 265,300 | Apr 2, 2026 |
| Mar 26, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +4,700 | $4.23 | $20k | 4,700 | Mar 26, 2026 |
| Mar 26, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative | -4,700 | $4.23 | $20k | 145,300 | Mar 26, 2026 |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Restricted Share Unitderivative | +10,000 | $0.00 | $0 | 10,000 | Apr 3, 2025 |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Restricted Share Unitderivative | +10,000 | $0.00 | $0 | 160,000 | Apr 3, 2025 |
| Nov 13, 2024 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +150,000 | $4.23 | $635k | 150,000 | Nov 13, 2024 |
Questions about Christiana Marie Cioffi
Answered from the filings on this page, as of the latest one.
Is Christiana Marie Cioffi buying or selling?
Christiana Marie Cioffi has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Christiana Marie Cioffi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Christiana Marie Cioffi has 0.
Where does Christiana Marie Cioffi file Form 4?
Christiana Marie Cioffi has filed Form 4 at FENC (FENNEC PHARMACEUTICALS INC.) as Chief Strategy Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.